Serum Lactate Dehydrogenase Level Prior to First‐Line Chemotherapy for Metastatic Urothelial Carcinoma Is a Prognostic Factor for Avelumab Maintenance Therapy: A Multicenter Retrospective Study
Normal serum lactate dehydrogenase level prior to first-line chemotherapy was a significant predictor of favorable response or prognosis for avelumab maintenance therapy in our cohort.
Authors
- Takahito Wakamiya (ORCID: https://orcid.org/0000-0001-9101-1749)
- Yasuo Kohjimoto (ORCID: https://orcid.org/0000-0001-6103-6320)
- Shimpei Yamashita (ORCID: https://orcid.org/0000-0001-7402-6164)
- Isao Hara
Institutions
- Wakayama Medical University (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1111/iju.70086
- Citations
- 4
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.03